XSHG
600763
Market cap2.97bUSD
Jul 25, Last price
46.05CNY
1D
10.01%
1Q
19.30%
Jan 2017
41.53%
Name
Topchoice Medical Co Inc
Chart & Performance
Profile
Topchoice Medical Corporation provides medical services in China. It provides various specialty medical services in oral, reproductive, and ophthalmology areas; and operates dental medical institutions and assisted reproductive medical institutions. It operates approximately 32 dental hospitals; and Tongze Dental College, a non-profit educational training organization. The company was formerly known as Topchoice Medical Investment Co., Inc. and changed its name to Topchoice Medical Corporation in November 2019. Topchoice Medical Corporation was founded in 1995 and is based in Hangzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 2,846,508 4.70% | 2,718,612 -2.23% | |||||||
Cost of revenue | 1,919,395 | 1,770,042 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 927,113 | 948,571 | |||||||
NOPBT Margin | 32.57% | 34.89% | |||||||
Operating Taxes | 130,434 | 122,306 | |||||||
Tax Rate | 14.07% | 12.89% | |||||||
NOPAT | 796,678 | 826,265 | |||||||
Net income | 500,475 -8.72% | 548,269 -21.99% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (1,005) | ||||||||
BB yield | 0.00% | ||||||||
Debt | |||||||||
Debt current | 80,088 | 140,923 | |||||||
Long-term debt | 2,198,572 | 1,996,300 | |||||||
Deferred revenue | 16,114 | 17,603 | |||||||
Other long-term liabilities | 2 | 2 | |||||||
Net debt | 528,360 | 455,490 | |||||||
Cash flow | |||||||||
Cash from operating activities | 839,951 | 670,050 | |||||||
CAPEX | |||||||||
Cash from investing activities | (884,180) | ||||||||
Cash from financing activities | 8,760 | ||||||||
FCF | 403,138 | 723,209 | |||||||
Balance | |||||||||
Cash | 594,463 | 630,322 | |||||||
Long term investments | 1,155,838 | 1,051,411 | |||||||
Excess cash | 1,607,975 | 1,545,803 | |||||||
Stockholders' equity | 4,223,425 | 3,718,215 | |||||||
Invested Capital | 3,804,539 | 3,129,036 | |||||||
ROIC | 22.98% | 28.94% | |||||||
ROCE | 17.04% | 20.17% | |||||||
EV | |||||||||
Common stock shares outstanding | 449,335 | 320,241 | |||||||
Price | 76.45 -50.03% | 152.99 -23.12% | |||||||
Market cap | 34,351,650 -29.89% | 48,993,626 -23.22% | |||||||
EV | 35,197,493 | 49,756,598 | |||||||
EBITDA | 1,116,462 | 1,121,876 | |||||||
EV/EBITDA | 31.53 | 44.35 | |||||||
Interest | 55,012 | 50,046 | |||||||
Interest/NOPBT | 5.93% | 5.28% |